BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33007422)

  • 1. Pepper component 7-ethoxy-4-methylcoumarin, a novel dopamine D2 receptor agonist, ameliorates experimental Parkinson's disease in mice and Caenorhabditis elegans.
    Li H; Feng Y; Chen Z; Jiang X; Zhou Z; Yuan J; Li F; Zhang Y; Huang X; Fan S; Wu X; Huang C
    Pharmacol Res; 2021 Jan; 163():105220. PubMed ID: 33007422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atractylon, a novel dopamine 2 receptor agonist, ameliorates Parkinsonian like motor dysfunctions in MPTP-induced mice.
    Li H; Wang F; Zhou Z; Jiang X; Li F; Feng Y; Liu C; Zhang Y; Fan S; Wu X; Huang C
    Neurotoxicology; 2022 Mar; 89():121-126. PubMed ID: 35104500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
    Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
    Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hordenine improves Parkinsonian-like motor deficits in mice and nematodes by activating dopamine D2 receptor-mediated signaling.
    Li H; Gao M; Chen Z; Zhou Z; Li W; Zhang X; Jiang X; Luo L; Li F; Wang G; Zhang Y; Huang X; Zhu J; Fan S; Wu X; Huang C
    Phytother Res; 2023 Aug; 37(8):3296-3308. PubMed ID: 36883794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differing short-term neuroprotective effects of the fibrates fenofibrate and bezafibrate in MPTP and 6-OHDA experimental models of Parkinson's disease.
    Kreisler A; Duhamel A; Vanbesien-Mailliot C; Destée A; Bordet R
    Behav Pharmacol; 2010 May; 21(3):194-205. PubMed ID: 20440202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vivo pharmacological evaluation of pardoprunox (SLV308)--a novel combined dopamine D(2)/D(3) receptor partial agonist and 5-HT(1A) receptor agonist with efficacy in experimental models of Parkinson's disease.
    Jones CA; Johnston LC; Jackson MJ; Smith LA; van Scharrenburg G; Rose S; Jenner PG; McCreary AC
    Eur Neuropsychopharmacol; 2010 Aug; 20(8):582-93. PubMed ID: 20434890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of neuroprotective compounds of caenorhabditis elegans dopaminergic neurons against 6-OHDA.
    Marvanova M; Nichols CD
    J Mol Neurosci; 2007; 31(2):127-37. PubMed ID: 17478886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    L'Episcopo F; Tirolo C; Caniglia S; Testa N; Serra PA; Impagnatiello F; Morale MC; Marchetti B
    J Neuroinflammation; 2010 Nov; 7():83. PubMed ID: 21092260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
    Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
    Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-linolenic acid suppresses dopaminergic neurodegeneration induced by 6-OHDA in C. elegans.
    Shashikumar S; Pradeep H; Chinnu S; Rajini PS; Rajanikant GK
    Physiol Behav; 2015 Nov; 151():563-9. PubMed ID: 26300470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity.
    Jing X; Shi H; Zhang C; Ren M; Han M; Wei X; Zhang X; Lou H
    Neuroscience; 2015 Feb; 286():131-40. PubMed ID: 25449120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D1 receptor agonism induces dynamin related protein-1 inhibition to improve mitochondrial biogenesis and dopaminergic neurogenesis in rat model of Parkinson's disease.
    Mishra A; Singh S; Tiwari V; Bano S; Shukla S
    Behav Brain Res; 2020 Jan; 378():112304. PubMed ID: 31626851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 7,8-dihydroxyflavone protects 6-OHDA and MPTP induced dopaminergic neurons degeneration through activation of TrkB in rodents.
    Luo D; Shi Y; Wang J; Lin Q; Sun Y; Ye K; Yan Q; Zhang H
    Neurosci Lett; 2016 May; 620():43-9. PubMed ID: 27019033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-apoptotic effect of modified Chunsimyeolda-tang, a traditional Korean herbal formula, on MPTP-induced neuronal cell death in a Parkinson's disease mouse model.
    Li H; Park G; Bae N; Kim J; Oh MS; Yang HO
    J Ethnopharmacol; 2015 Dec; 176():336-44. PubMed ID: 26593210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
    Liu LX; Chen WF; Xie JX; Wong MS
    Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carpesii fructus extract exhibits neuroprotective effects in cellular and Caenorhabditis elegans models of Parkinson's disease.
    Zhu FD; Wang BD; Qin DL; Su XH; Yu L; Wu JM; Law BY; Guo MS; Yu CL; Zhou XG; Wu AG
    CNS Neurosci Ther; 2024 Apr; 30(4):e14515. PubMed ID: 37905594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurorescue Effects of Frondoside A and Ginsenoside Rg3 in
    Chalorak P; Sanguanphun T; Limboonreung T; Meemon K
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maackiain Ameliorates 6-Hydroxydopamine and
    Tsai RT; Tsai CW; Liu SP; Gao JX; Kuo YH; Chao PM; Hung HS; Shyu WC; Lin SZ; Fu RH
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32585871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.